Factors Affecting Cervical Cancer Screening Among Women Living with HIV in Ndola District
Authors
Institute of Biomedical and Health Sciences, Mukuba University, Kitwe (Zambia)
Center for infectious Disease and Research in Zambia, Angola street Kanseshi, Ndola (Zambia)
Institute of Biomedical and Health Sciences, Mukuba University, Kitwe (Zambia)
Article Information
DOI: 10.47772/IJRISS.2026.100300325
Subject Category: Health Science
Volume/Issue: 10/3 | Page No: 4385-4402
Publication Timeline
Submitted: 2026-03-20
Accepted: 2026-03-25
Published: 2026-04-07
Abstract
The cervix is the lower, narrow part of the uterus in the female reproductive system and connects the uterus to the vagina, forming part of the birth canal. In 2018, Zambia had the third highest incidence of cervical cancer in the world with 66.4 new cases per 100,000 women despite the establishment of the Cervical Cancer Prevention Program in Zambia (CCPPZ) in 2006. The high incidence of cervical cancer is linked to the heavy burden of HIV and AIDS. Globally, approximately 311,000 women died from cervical cancer in 2018, with over 570,000 living with the disease. Although there is substantial literature on factors affecting cervical cancer (CACX) screening among women living with HIV worldwide, there is inadequate knowledge on this topic in Ndola District of the Copperbelt Province. This descriptive cross-sectional study was conducted in Ndola District using a quantitative data collection method through a semi-structured questionnaire administered to women living with HIV aged above 15 years. Participants were selected using simple random sampling and were clients on ART for at least 12 months at their respective facilities. Data were entered in Excel and imported into STATA version 14.0 statistical software, where descriptive, chi-square, and logistic regression analyses were performed using a 95% confidence level. Out of the 400 participants, 67% had not been screened for CACX in the past 12 months while only 33% had been screened, indicating that screening coverage remains below the 75% target. The main reasons cited for not accessing screening were fear of pain during the procedure (43%), being shy (30.75%), lack of awareness of the service (13%), long distance to the facility (11.25%), and lack of qualified staff (2%). The study revealed low uptake of CACX screening services among women living with HIV, mainly associated with fear of pain and shyness.
Keywords
Cervical cancer screening (CACX), Uptake of screening services, Barriers to screening
Downloads
References
1. Gutusa, F. and Roets, L. (2023) ‘Early cervical cancer screening: The influence of culture and religion’, African Journal of Primary Health Care & Family Medicine, 15(1), pp. 1–6. [Google Scholar] [Crossref]
2. https://doi.org/10.4102/phcfm.v15i1.3776. [Google Scholar] [Crossref]
3. Kabalika, C., Mulenga, D., Mazaba, M.L. and Siziya, S. (2018) ‘Acceptance of cervical cancer screening and its correlates among women of a peri-urban high-density residential area in Ndola, Zambia’, International Journal of Maternal and Child Health and AIDS, 7(1), pp. 17–27. https://doi.org/10.21106/ijma.223 [Google Scholar] [Crossref]
4. Kalubula, M., Shen, H., Makasa, M. and Liu, L. (2021) ‘Epidemiology of cancers in Zambia: A significant variation in cancer incidence and prevalence across the nation’, Malawi Medical Journal, 33(3), pp. 186–195. https://doi.org/10.4314/mmj.v33i3.6. [Google Scholar] [Crossref]
5. Kim, S.J., Han, K.T. and Park, E.C. (2016) ‘Impact of job status on accessibility of cancer screening’, Cancer Research and Treatment, 48(2), pp. 825–833. https://doi.org/10.4143/crt.2015.040. [Google Scholar] [Crossref]
6. Lubeya, M.K., Chima, P., Phiri, C. et al. (2021) ‘Cervical cancer screening uptake among HIV positive women seeking healthcare services at a tertiary hospital in Lusaka, Zambia’, Health Press Zambia Bulletin. [Google Scholar] [Crossref]
7. Macrotrends (2023) Ndola, Zambia metro area population 1950–2023. Available at: https://www.macrotrends.net/cities/23279/ndola/population (Accessed: 23 June 2023). [Google Scholar] [Crossref]
8. Maria, S. et al. (2022) ‘Cervical cancer screening among HIV-positive women in urban Uganda: A cross-sectional study’, Makerere University College of Health Sciences, Kampala, Uganda. [Google Scholar] [Crossref]
9. Mengesha, M.B., Chekole, T.T. and Hidru, H.D. (2023) ‘Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub-Saharan Africa: A systematic review and meta-analysis’, BMC Women’s Health, 23, p. 338. https://doi.org/10.1186/s12905-023-02479-w. [Google Scholar] [Crossref]
10. Mwanza, M.J., Chibuye, B.J. and Musakabantu, A. (2026) ‘Evaluation of factors contributing to low TB detection rate in selected facilities of Ndola District’, International Journal of Current Science Research and Review, 9(3), pp. 1292–1303. https://doi.org/10.47191/ijcsrr/V9-i3-19 [Google Scholar] [Crossref]
11. Mwantake, M.R., Kajoka, H.D., Kimondo, F.C., Amour, C. and Mboya, I.B. (2022) ‘Factors associated with cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania: A cross-sectional study’, Preventive Medicine Reports, 30, p. 101985. https://doi.org/10.1016/j.pmedr.2022.101985. [Google Scholar] [Crossref]
12. Ndejjo, R., Mukama, T., Musabyimana, A. and Musoke, D. (2016) ‘Uptake of cervical cancer screening and associated factors among women in rural Uganda: A cross-sectional study’, PLoS One, 11(2), p. e0149696. https://doi.org/10.1371/journal.pone.0149696. [Google Scholar] [Crossref]
13. Schiffman, M.H. et al. (1993) ‘Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia’, JNCI: Journal of the National Cancer Institute, 85(12), pp. 958–964. https://doi.org/10.1093/jnci/85.12.958. [Google Scholar] [Crossref]
14. Small, W. et al. (2017) ‘Cervical cancer: A global health crisis’, Cancer, 123(13), pp. 2404–2412. https://doi.org/10.1002/cncr.30667. [Google Scholar] [Crossref]
15. Stelzle, D., Tanaka, L.F., Lee, K.K., Khalil, A.I. et al. (2021) ‘Estimates of the global burden of cervical cancer associated with HIV’, The Lancet Global Health, 9(2), pp. 161–169. https://doi.org/10.1016/S2214-109X(20)30459-9. [Google Scholar] [Crossref]
16. Tapera, O., Dreyer, G., Kadzatsa, W., Nyakabau, A.M., Stray-Pedersen, B. and Hendricks, S. (2019) ‘Cervical cancer knowledge, attitudes, beliefs and practices of women aged at least 25 years in Harare, Zimbabwe’, BMC Women’s Health, 19(1), p. 91. https://doi.org/10.1186/s12905-019-0790-6. [Google Scholar] [Crossref]
17. Washburn, R. (2020) Understanding the Health Belief Model. Department of Family and Consumer Sciences, University of Tennessee. [Google Scholar] [Crossref]
18. World Health Organization (WHO) (2020) Costing the national strategic plan on prevention and control of cervical cancer: Zambia 2019–2023. Geneva: WHO. Available at: https://cdn.who.int/media/docs/default-source/cervical-cancer/zambia-cxca-costing-report-20201112.pdf (Accessed: 21 April 2021). [Google Scholar] [Crossref]
19. World Health Organization (WHO) (2020) Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO. [Google Scholar] [Crossref]
20. World Health Organization (WHO) (2021) Boosting cervical cancer screening in women living with HIV in Zambia. [Google Scholar] [Crossref]
21. Worldometers (2023) World population statistics. Available at: https://www.worldometers.info/ (Accessed: 23 June 2023). [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
- Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
- Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
- Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
- Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review